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Abstract
Expression of Norwalk virus nonstructural polyprotein precursor in vitro resulted in rapid cotranslational cleavage at specific sites. The
cleavage products were similar to those previously identified for Southampton virus, a highly related virus. We inactivated the virally
encoded proteinase responsible for cleavage of the nonstructural polyprotein by mutation of the putative catalytic cysteine residue, which
resulted in production of full-length polyprotein precursor. NV proteinase was expressed in Escherichia coli as a glutathione S-transferase
fusion and purified by GST-affinity chromatography. Activity of the purified proteinase was demonstrated by incubation with the full-length
precursor protein. trans cleavage of the nonstructural protein precursor resulted in cleavage products similar to those observed during
cotranslational cleavage, however, at lesser efficiency. NV proteinase displayed sensitivities to cysteine and serine protease inhibitors similar
to poliovirus 3C proteinase, suggesting that NV proteinase is a member of the viral cysteine proteinase family. We propose that the
proteinase may play a regulatory role in viral replication.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Positive strand RNA viruses with small genomes typi-
cally express polyprotein precursors during infection that
are processed by site-specific cleavage mediated by either
viral or cellular proteases. In many cases, viral replication is
regulated by proteolytic processing, with larger precursors
exhibiting different functions than the mature proteins
(Lawson and Semler, 1992). Viruses in the family Calici-
viridae use this strategy to express nonstructural proteins
(Green et al., 2001). Despite increasing knowledge of viral
genomic structure, studies on virus replication have been
hampered by lack of a cell culture system. Experiments
using in vitro technologies help define the role of nonstruc-
tural proteins in viral replication and aid in the development
of antiviral drugs.
Norwalk virus (NV) is the prototype virus of the Nor-
walk-like virus genus within the Caliciviridae family. Nor-
walk-like viruses are a major cause of acute gastroenteritis
in humans (Glass et al., 2000b; Koopmans et al., 2000).
Norwalk-like viruses are associated with sporadic disease as
well as foodborne outbreaks. It was estimated that Norwalk-
like viruses cause over 23 million cases of gastroenteritis
annually in the United States associated with foodborne
transmission (Mead et al., 1999).
NV is composed of a positive sense single-strand RNA
genome surrounded by an icosahedral capsid. The viral
genome contains three open-reading frames (Hardy and
Estes, 1996; Jiang et al., 1993). Open-reading frame 1
(ORF1) encodes a single polyprotein that is the precursor to
the nonstructural proteins. Functional domains within the
polyprotein were proposed based on genomic sequence ho-
mology with picornaviruses (Jiang et al., 1993) and include
helicase, proteinase, and RNA-dependent RNA polymerase
motifs. ORFs 2 and 3 encode the major capsid protein (Jiang
et al., 1992) and a minor structural protein (Glass et al.,
2000), respectively. The Norwalk virus capsid is composed
of 90 dimers of the ORF2 protein (Prasad et al., 2000).
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Expression of this protein using a baculovirus expression
system results in spontaneous assembly of the capsid pro-
tein into virus-like particles that are structurally and anti-
genically similar to the virus (Jiang et al., 1992). These
particles are being evaluated as a candidate vaccine for
prevention of Norwalk virus-induced gastroenteritis (Ball et
al., 1999; Estes et al., 2000).
Proteolytic processing of calicivirus polyproteins from
Southampton virus (SV), feline calicivirus (FCV), and rab-
bit hemorrhagic disease virus (RHDV) (Alonso et al., 1996;
Liu et al., 1996; Meyers et al., 2000; Sosnovtseva et al.,
1999) has been studied extensively. A map of the cleavage
sites in the ORF1 polyprotein was determined for SV by
expressing different length precursors either by in vitro
translation (Liu et al., 1996) or bacterial expression in Esch-
erichia coli (Liu et al., 1999). Proteolytic cleavage occurs at
glutamine-glycine or glutamate-glycine/alanine junctions at
the boundaries of the mature polypeptides. Alignment of
amino acid sequences of ORF1 from a number of calicivi-
ruses with that of SV showed that sequences at the identified
cleavage sites were highly conserved (Pletneva et al., 2001),
suggesting conservation of processing recognition sites in
the related viruses.
A number of observations suggest that NV encodes a
proteinase that is a member of the viral cysteine-proteinase
family. Viral cysteine proteinases, exemplified by the well-
characterized picornaviral proteinases, share structural and
functional similarities (Rawlings and Barrett, 1994). The
viral cysteine proteinases contain a catalytic triad, com-
prised of conserved cysteine, histidine, and aspartic acid
residues. In addition, proteinases in this family, while uti-
lizing an active site cysteine, share structural homology with
serine proteinases (Malcom, 1995). Alignment of the pro-
teinase region of NV ORF1 with amino acid sequences of
several picornaviruses showed a conserved sequence motif
surrounding the putative catalytic residue (Jiang et al.,
1993). The proteinase of Chiba virus, a member of the
Norwalk-like virus group, demonstrated a substrate speci-
ficity similar to human rhinovirus 3C proteinase (Someya et
al., 2000).
In this report, we investigated the proteolytic processing
of the NV nonstructural proteins and characterized the vi-
rally encoded proteinase responsible for their cleavage. We
describe processing of the NV polyprotein by two methods,
autocatalytic proteolytic cleavage modulated by endog-
enously expressed proteinase (cleavage in cis) and exoge-
nous addition of the NV proteinase to the polyprotein sub-
strate (cleavage in trans). Results from these studies
indicate that the proteinase cleaves the nonstructural
polyprotein at specific sequence junctions, both in cis and
trans. The proteinase displays a detectable cleavage site
preference, with glutamine/glycine junctions being pre-
ferred.
Results
Processing of NV nonstructural protein
A proteolytic cleavage map of Southampton virus non-
structural proteins was previously defined (Liu et al., 1996,
1999). NV and SV are highly related with 86% amino acid
identity in ORF1. Alignment of the amino acid sequence of
NV and SV ORF1 revealed that the amino acids at each
cleavage site were conserved, suggesting utilization of the
same sites (Table 1).
To analyze the processing of the NV polyprotein, ORF1
(nt 5–5374) was subcloned into pCITE4a and used to direct
in vitro transcription-translation reactions in rabbit reticu-
locyte lysate (RRL). Translation of ORF1 resulted in pro-
duction of 3 bands corresponding in size to those expected
based on the SV cleavage profile (Fig. 1B, lane 2). The
products of 45, 40, and 114 kDa were predicted to result
from cleavage at primary recognition sites located at amino
acid residues 398 and 761 (Fig. 1A), based on homology to
the corresponding sites in SV (Table 1). Accumulation of
the full-length protein was not observed, suggesting co-
translational cleavage.
The codon for cysteine residue at amino acid 1239,
predicted to be the catalytic residue in the proteinase based
on sequence homology to picornavirus proteinases (Jiang et
al., 1993), was mutated to a glycine codon by site-directed
Table 1
Cleavage sites in Southampton and Norwalk viruses
Virus Site aaa P4 P3 P2 P1a P1 P2 P3 P4
SV 1 399 F H L Q G P E D
2 762 F Q L Q G K M Y
3 961 A T M E G K N K
4 1099 I S F E A P P T
5 1280 T T L E G G D K
NV 1 398 F H L Q G P E D
2 761 F Q L Q G P T Y
3 962 A V P E G K N K
4 1100 I N F E A P P T
5 1281 T A L E G G D K
a Cleavage follows P1.
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mutagenesis. The resulting plasmid (pCITE/ORF1C1239G)
was transcribed and translated in vitro and produced full-
length ORF1, which migrates at approximately 200 kDa
(Fig. 1B, lane 3). Immunoprecipitation of both translation
reactions with S-agarose that binds a S-epitope at the amino-
terminus resulted in precipitation of the 45 kDa band in the
processed ORF1 and the full-length band in the mutant
version (Fig. 1B, lanes 5 and 6).
Purification of NV proteinase
The cleavage product of ORF1 that is predicted to cor-
respond to the mature viral proteinase is located between
amino acid residues 1101 and 1281 (Fig. 1A). The region of
the cDNA encoding the proteinase was subcloned into the
bacterial expression vector, pET41a, as an amino-terminal
GST fusion. The GST-NV proteinase was efficiently ex-
pressed in BL21 CodonPlus (DE3) cells and purified by
GST affinity chromatography (Fig. 2). The amino terminal
GST tag was subsequently removed by cleavage with
thrombin (Fig. 2B, lane 3).
Analysis of proteolytic activity of purified proteinase
In order to assess the ability of NV proteinase to cleave
its natural substrate in trans, full-length 35S-labeled ORF1
Fig. 1. (A) Organization of the NV genome and the predicted protein products derived from ORF1. Schematic representation of the positive-sense RNA
genome of NV depicts 5 VPg, location of the 3 open-reading frames, and presence of poly(A)tail. The predicted protein products are indicated with
corresponding sizes determined based on amino acid sequence; full-length polyprotein (200 kDa), primary cleavage products (45, 40, and 114 kDa), and
secondary cleavage of the 114 protein to 4 mature proteins (22, 15, 20, and 55 kDa). Amino acids located at cleavage junctions are shown. 3C and 3D
represent the proteinase and RNA-dependent RNA polymerase, respectively. (B) 35S-labeled in vitro translation products were analyzed by SDS-PAGE and
autoradiography as follows: lane 1, luciferase; lane 2, NV ORF1; lane 3, ORF1C1239G. The translation reactions were immunoprecipitated with S-agarose,
which binds S-epitope located at the amino-terminus of ORF1 (lane 4, luciferase; lane 5, NV ORF1; lane 6, ORF1C1239G).
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synthesized by in vitro translation was incubated with pu-
rified proteinase. Cleavage products were analyzed by SDS-
PAGE and compared to cleavage products produced by cis
cleavage (Fig. 3). Cleavage of ORF1 by exogenous protein-
ase resulted in products of 114, 84, 45, and 40 kDa (Fig. 3,
lane 3). The protein products of 114, 45, and 40 correspond
to those observed in cis-processed ORF1 (Fig. 3, lane 1);
however, the protein migrating at approximately 84 kDa
was not previously observed. We predicted that this protein
results from preferential cleavage at aa 761. We confirmed
that this protein corresponds to the amino terminus of the
polyprotein by immunoprecipitation with S-agarose (data
not shown). Accumulation of the 84-kDa protein observed
in trans processing of the full-length ORF1 suggests that
intramolecular proteolysis is more efficient and may be the
preferred pathway during viral replication.
To help confirm the designation of cleavage sites, the
codons for amino acid 398 and 761 were changed indepen-
dently from glutamine to proline by site-directed mutagen-
esis to eliminate the predicted cleavage site. Translation and
subsequent processing of the altered ORF1 proteins resulted
in elimination of cleavage at the mutated site (Fig. 3, lanes
4 and 5). Introduction of a proline residue at aa 398 resulted
in a protein migrating identically to the 84-kDa band seen in
trans and corresponding loss of the 45- and 40-kDa bands
(Fig. 3, lane 4). This result indicates that the 84-kDa protein
observed during cleavage of ORF1 by NV proteinase in
trans is the precursor to the 45- and 40-kDa proteins. Sim-
ilar results were obtained in trans, when the cleavage site
mutant (Q398P) was introduced into the expression plasmid
for ORF1 lacking an active proteinase and was incubated
with purified proteinase (data not shown). Introduction of a
proline residue at aa 761 resulted in 2 cleavage products, the
45-kDa amino-terminus and a larger protein of approxi-
mately 154 kDa, resulting from fusion of the 40- and 114-
kDa proteins (Fig. 3, lane 5). These results are consistent
with the identity of the cleavage sites being those predicted
based on the SV mapping studies.
Kinetic analysis of ORF1 cleavage
When NV ORF1 was translated in vitro no full-length
protein was detected. Kinetic analysis of cis cleavage was
performed by analyzing aliquots of the in vitro translation
reaction at various time points during the incubation period.
35S-labeled protein was first detected after 30 min (Fig. 4A).
At this early time point, cleavage products are present and
full-length ORF1 was not. At later time points, increasing
amounts of cleavage products were accumulated. These
results suggest the major processing events of ORF1 occur
either cotranslationally or rapidly after translation.
Similar analysis was performed for trans cleavage of
ORF1. 35S-labeled ORF1 was incubated in the presence of
purified NV proteinase and the reaction stopped at various
time points during incubation. Increasing amounts of cleav-
age products accumulate over time (Fig. 4B). However, the
main cleavage products produced do not undergo further
processing using this in vitro assay system.
Sensitivity to protease inhibitors
The NV proteinase was characterized further by exam-
ining the sensitivity to a panel of protease inhibitors. Insight
into the catalytic mechanism of many viral proteinases has
come from inhibition studies (Seipelt et al., 1999). Previous
studies demonstrated that poliovirus 3C proteinase activity
was inhibited by serine protease inhibitors, such as TPCK,
PMSF, and 3,4-dichloroisocoumarin (Baum et al., 1991), in
Fig. 3. Cleavage products resulting from cis and trans cleavage of ORF1 by
NV proteinase. The plasmids were translated in vitro and analyzed as
described under Methods for lanes 1, 4, and 5. Lanes 2 and 3, aliquots of
TNT reactions were diluted in proteinase buffer and incubated in the
absence (lane 2) or presence of purified NV proteinase (lane 3) for 60 min
at 30°C. Equivalent amounts of TNT reactions were loaded. Lane 1, ORF1;
lane 2, ORF1C1239G; lane 3, ORF1C1239G  purified NV proteinase;
lane 4, ORF1Q398P; lane 5, ORF1Q761P.
Fig. 2. Expression and purification of NV proteinase. (A) BL21-Codon-
Plus(DE3)-RIL cells containing the plasmid pET41a/pro were analyzed for
expression of proteinase by SDS-PAGE and stained with Coomassie bril-
liant blue. Lane 1, molecular weight standards; lane 2, cell lysate prior to
IPTG induction; lane 3, cell lysate 3 h after IPTG induction. (B) GST-
proteinase was purified by GST affinity chromatography (lane 2). Fusion
protein was cleaved with thrombin and the GST tag was removed by GST
affinity chromatography to yield purified proteinase (lane 3). The sizes of
GST-proteinase fusion and NV proteinase are indicated by arrows.
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addition to cysteine protease inhibitors. Additionally, struc-
tural studies suggest that the picornaviral 3C proteinases
exhibit serine proteinase-like folds (Malcom, 1995). We
tested a panel of commercially available protease inhibitors
for their ability to inhibit NV proteinase activity in vitro.
35S-labeled full-length ORF1 was incubated in the absence
or presence of NV proteinase; each inhibitor was added at
different concentrations ranging up to 100-fold (Table 2).
Cleavage products were quantified following separation on
SDS-PAGE by densitometric analysis (Fig. 5). Strong inhi-
bition of proteinase activity was observed with zinc chlo-
ride, an inhibitor of cysteine proteases, and TPCK, a serine
protease inhibitor. Pefabloc, TLCK, and PMSF, all serine
protease inhibitors, inhibited the activity of NV proteinase
to lesser extent. Cysteine protease inhibitors, such as E-64,
and the serine proteinase inhibitor, leupeptin, did not inhibit
NV proteinase. Similar inhibitor susceptibilities were found
in studies with FCV proteinase-mediated cleavage of the
feline calicivirus capsid precursor (Sosnovtsev et al., 1998).
The observed inhibitor sensitivity and the fact that the
protease activity is lost when cys 1239 is replaced by gly-
cine suggest that the NV proteinase is mechanistically and
structurally similar to other viral cysteine proteinases.
Cleavage at secondary sites
Cleavage at the predicted sites in the 114-kDa precursor
was not observed following in vitro translation of ORF1. It
is possible that the differences in amino acid composition
surrounding the cleavage site affect site preferences of the
proteinase (Table 1). For example, efficient cleavage is
observed at aa 398 and 761, where cleavage occurs at
glutamine-glycine pairs. The secondary cleavage sites were
identified in SV at glutamate-glycine (aa 961 and 1280) or
glutamate-alanine (aa 1099) residues by expression of the
carboxyl-terminal domain of ORF1 in E. coli (Liu et al.,
1999). We expressed the region of NV ORF1 comprosed of
the proteinase-polymerase fusion protein (pro-pol) using the
E. coli vector, pET41a. Full-length GST-pro-pol was de-
tected at lower levels than previously seen with the GST-
proteinase fusion. A band corresponding in size to GST-
proteinase was also detected, suggesting that cleavage was
occurring at the pro-pol junction. Expression and processing
of the pro-pol protein was examined further by performing
a time course of expression. Aliquots of cells were har-
vested at 0, 15, 30, 45, 60, 120, and 240 min after induction
with IPTG and expression of the proteinase and polymerase
was examined by Western blotting using polyclonal antisera
against NV polymerase (Fig. 6A) or proteinase (Fig. 6B).
The full-length pro-pol fusion is present in early time points,
but does not accumulate with time. At later time points, the
full-length protein was not detected. Comparison of the
Western blot with antisera raised against NV proteinase and
polymerase showed that the proteinase is present after over-
night culture, but the polymerase is not. This result indicates
that the polymerase is not stable when expressed in E. coli.
The results of the bacterial expression study demonstrated
Fig. 4. Kinetic analysis of ORF1 cleavage. (A) Cis cleavage of ORF1. pCITE/ORF1 was used to direct translation using TNT-coupled transcription/translation
system. Aliquots were removed at the indicated time points (min.) and analyzed by SDS-PAGE and fluorography. (B) 35S-labeled full-length ORF1 protein
was incubated with purified NV proteinase (1 g) at 30°C. Aliquots were removed at the indicated time points and reaction was stopped by addition of
SDS-dissociation buffer. Samples were analyzed by SDS-PAGE and fluorography.
Table 2
Sensitivity of NV proteinase to protease inhibitors
Inhibitor Concentration range Inhibition
Antipain 5–500 g/ml 
Bestain 4–400 g/ml 
E-64 1–100 g/ml 
Leupeptin 0.5–50 g/ml 
Pefabloc 50–5000 g/ml 
Aprotinin 0.2–20 g/ml 
PMSF 17.5–750 g/ml 
TLCK 12.5–375 g/ml 
TPCK 10–500 g/ml 
Zinc chloride 0.25–25 mM 
 indicates complete cleavage.  indicates inhibition at the highest
concentration only.  indicates total inhibition at highest concentration
and total or partial inhibition at lower concentrations
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that the proteinase is active and cleaves at the junction
between the proteinase and polymerase cotranslationally
(Fig. 6). Expression of the pro-pol fusion, in which the
active site cysteine was mutated to a glycine, resulted in
production of the fusion protein (data not shown) and con-
firmed that cleavage at the pro-pol junction was not medi-
ated by an E. coli proteinase.
In order to evaluate whether cleavage at any secondary
site could be enhanced, we changed the cleavage recogni-
tion sites to glutamine-glycine pairs at amino acids 962,
1100, and 1282 (Fig. 1) by site-directed mutagenesis. Pro-
teins containing these amino acid substitutions were cleaved
similarly to that seen with the parental protein (Fig. 7).
However, a cleavage product migrating more slowly than
the amino-terminal 45-kDa peptide was observed. It was
possible that this product was derived from cleavage at a
secondary site. In order to determine if the product corre-
sponded to a carboxyl-terminal fragment, the translation
reaction was immunoprecipitated with an antibody to the
carboxyl-terminal His-tag. The His-tag mAb recognized
proteins of 114, approximately 75, and 55 kDa (Fig. 7). The
two smaller bands correspond in size to that predicted for
the pro-pol precursor and mature polymerase. The presence
of higher molecular weight products specifically enriched
by immunoprecipitation with the anti-His mAb suggests
that cleavage occurs at the secondary cleavage sites during
in vitro translation, but is much less efficient than cleavage
at the primary sites. Alteration of the sequence at the cleav-
age site enhanced cleavage efficiency slightly. It is possible
that either sequences flanking the cleavage site or secondary
structure of the precursor is important to the specificity of
cleavage.
Discussion
Our inability to grow Norwalk virus in cell culture pre-
cludes study of the mechanisms involved in replication.
Fig. 5. Sensitivity of NV proteinase to protease inhibitors. [35S]Methionine-labeled ORF1 was incubated in the absence (lane 1) or presence of NV proteinase
(lane 2) and used to normalize quantification of amount of cleavage for each gel. Protease inhibitors were added as indicated in figure. (A) Pefabloc, 5, 0.5,
and 0.05 mg/ml (lanes 3–5); zinc chloride, 25, 2.5, and 0.25 mM (lanes 6–8), and TPCK, 500, 100, and 10 g/ml (lanes 9–11). (B) TLCK, 375, 125, and
12.5 g/ml (lanes 3–5), and PMSF, 750, 175, and 17.5 g/ml (lanes 6–8). (C) Leupeptin, 50, 5, and 0.5 g/ml (lanes 3–5). Data for inhibitors not shown
are included in Table 2.
Fig. 6. Cleavage at the proteinase-polymerase junction observed following
expression in E. coli. E. coli BL21 codon plus cells containing pET41a/
pro-pol were induced with IPTG. Samples were removed at the indicated
time points and expression was monitored by Western blotting with anti-
sera against NV polymerase (A) and proteinase (B). Arrows indicate
pro-pol fusion and cleavage products. Time points are 0, 15, 30, 45, 60,
120, and 240 min and overnight (lanes 2–9).
Fig. 7. Identification of cleavage within 114-kDa precursor. Plasmids
encoding ORF1 (lanes 1–2) and enhanced cleavage site mutants, E962Q
(lanes 3 and 4), E1100Q/G (lanes 5 and 6), and E1282Q (lanes 7 and 8)
were translated in TNT T7 quick-coupled transcription/translation system
and analyzed by SDS-PAGE. TNT reactions were immunoprecipitated
with an anti-His mAb as indicated. Arrows indicate novel cleavage prod-
ucts detected by immunoprecipitation.
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Thus, most of our understanding of calicivirus replication
has come from studies of feline calicivirus, which is able to
grow in culture, or investigation of caliciviruses using in
vitro techniques. For example, reports on cloning and se-
quencing of the Norwalk virus genome provided the basis
for understanding genomic organization and prediction of
protein function based on sequence homology (Jiang et al.,
1990). Additional studies on recombinant protein expres-
sion and assembly of the capsid proteins provide insight into
the structure of the virus (Jiang et al., 1992; Prasad et al.,
1999). In this report, we have purified and characterized the
NV proteinase and examined processing of the nonstruc-
tural polyprotein in vitro.
The mechanism of translation initiation during calicivi-
rus replication is unknown. The genome is capable of serv-
ing as mRNA, but lacks either a 5-cap structure or any
identified IRES. The genome contains a VPg protein linked
to the 5 end of both the genome and the subgenomic RNAs
(Burroughs and Brown, 1978; Meyers et al., 1991), which
may play a role in translation initiation (Herbert et al., 1997;
Sosnovtsev et al., 1995). In our studies of NV, translation of
NV RNA produced from a full-length cDNA clone in vitro
was inefficient both in RRL and in transfected cells. The
efficiency and specificity of translation were enhanced by
expressing ORF1 from transcripts containing an IRES and
supplementing the RRL with potassium and magnesium.
Translation in the absence of added divalent cations resulted
in production of multiple bands, suggesting incorrect trans-
lation initiation.
Translation of NV ORF1 yielded 3 major protein prod-
ucts similar to those produced by SV (Liu et al., 1996).
These products are derived from cotranslational proteolytic
processing of the polyprotein by the virally encoded pro-
teinase. Mutagenesis of the predicted catalytic cysteine res-
idue abolished processing and resulted in production of the
full-length polyprotein precursor. Overexpression of the NV
proteinase domain in E. coli resulted in an enzyme that was
catalytically active either as a fusion or mature protein. The
purified proteinase cleaved NV ORF1 in trans with the
same cleavage specificity as in cis, however, with decreased
efficiency. NV proteinase was also able to cleave casein in
a nonspecific protease assay (unpublished observation).
Characteristics of the NV proteinase suggest it is similar to
picornavirus and other calicivirus proteinases with respect
to its mechanism of action and substrate specificity. Future
studies will involve structural characterization of the NV
proteinase, although preliminary modeling studies suggest
the potential for a serine proteinase-like fold.
The ability of Norwalk virus to regulate the activity of
viral proteins involved in replication is suggested by the
observation that cleavage occurs preferentially at certain
sites. Picornaviruses (Racaniello, 2001) and alphaviruses
(Shirako and Strauss, 1994) use a regulated protein-process-
ing cascade to produce cleavage products with functions
distinct from those of their precursors. A similar mechanism
has been proposed for SV (Clarke and Lambden, 2000). In
order to investigate the role of NV proteinase in regulating
viral replication, additional assays to monitor the functions
of distinct precursor proteins are required. We produced
both the pro-pol precursor and the polymerase proteins in E.
coli, with the intention of characterizing proteinase and
polymerase activity of purified proteins. Proteolysis medi-
ated by the NV proteinase was observed during expression
of pro-pol precursor protein. Sosnovtseva et al. (1999) dem-
onstrated that the proteinase-polymerase precursor is a sta-
ble product during FCV infection. It was further demon-
strated that the proteinase-polymerase precursor is the
active form of the FCV polymerase (Wei et al., 2001).
Norwalk-like viruses are major etiologic agents of acute
nonbacterial gastroenteritis. Therefore, rapid intervention
with an antiviral agent that limits both the severity of the
disease and the transmission of the virus is of significant
importance and will have an impact on human health. The
availability of purified and well-characterized proteinase
provides an important reagent for the development of pro-
teinase inhibitors that could be used as an antiviral inter-
vention.
Materials and methods
Plasmid construction
Standard recombinant DNA methods were used for plas-
mid construction. All Norwalk virus sequence is based on
GenBank Accession Number M87661. A NV full-length
genomic cDNA clone (pSPNV-FL), provided by Dr. Mary
Estes, Baylor College of Medicine, was used as the template
for subcloning ORF1, proteinase, and proteinase-polymer-
ase constructs. NV ORF1 (nt 8–5371) was amplified by
PCR from pSPNV-FL with the primers, 5-GAGCGGATC-
CATGATGGCGTCAAAAGACGTCG-3 and 5-AGTC-
CTCGAGGACGCCATCATCATTTACGAATTC-3. The
PCR product was digested with BamHl and Xhol and cloned
into the corresponding sites in pCITE4a (Novagen), down-
stream of a T7 RNA polymerase promoter and EMCV
IRES. The NV ORF1 polyprotein is expressed as a fusion
with a S-tag epitope at the amino-terminus and an His-tag at
the carboxyl-terminus.
The region of NV ORF1 encoding the proteinase (nt
3305–3848) and proteinase-polymerase (pro-pol; nt 3305–
5371) domains were amplified by PCR with the primers,
5-TCGACAAGAGTCCCGCTCCCCCGACACTATG-3 and
5-ATGGCGCGCCTTATTCTAGTGCGGTTTCG-3 for pro-
tease or 5-ATGGCGCGCCTTAGACGCCATCATC-3 for
pro-pol fusion. The PCR products were digested with PshAl
and Ascl and cloned into corresponding sites of pET41a
(Novagen), downstream of a T7 RNA polymerase promoter.
The proteins are expressed as amino-terminal fusions with
glutathione S-transferase (GST), His-tag, and S-tag.
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Site-directed mutagenesis
Site-directed mutagenesis was performed using the
QuikChange mutagenesis system (Stratagene) according to
the manufacturer’s directions. The codon for cysteine 1239
(nt 3719–3721) in pCITE/ORF1 was replaced with a gly-
cine codon by mutagenesis of nt 3719 from T to G. The
resulting plasmid was designated pCITE/ORF1C1239G.
The cleavage recognition sites at amino acids 398 and
761 in ORF1 were modified by replacing the glutamine
coding sequences with proline codons. For gln 398, nt 1197
was changed from A to C, and gln 761 was changed to pro
by replacing nt 2286 A with C.
Three predicted cleavage sites, located at the junctions
adjacent to VPg, proteinase, and polymerase domains
within ORF1, contain glutamic acid residues at the P1
position and glycine or alanine residues at the P1 position
(Table 1). Codons for the glutamic acid residues were mod-
ified to encode glutamine and the alanine codon was mod-
ified to encode a glycine. Glu 962 was replaced with gln by
changing base 2288 from G to C. Glu 1100 and ala 1101
were replaced with gln and gly, respectively, by changing nt
3302 from G to C and 3306 from C to G. Glu 1282 was
replaced with gln by changing nt 3845 from G to C. All base
changes were confirmed by sequencing.
In vitro transcription-translation and immunoprecipitation
One microgram of plasmid DNA was used as transcrip-
tion template in coupled in vitro transcription-translation
reactions (TNT T7 Quick Coupled Reticulocyte Lysate Sys-
tem; Promega) with [35S]methionine (Redivue; Amersham).
We found that efficient and complete translation of ORF1 in
the RRL required the addition of 20 mM potassium chloride
and 0.5 mM magnesium acetate (PCR enhancer; Promega).
Reactions were incubated at 30°C for 90 min or as specified
in the figure legends. Samples (5 l) of the translation
reactions were solubilized in SDS-PAGE sample buffer,
heated at 100°C for 5 min, and separated in 8–16% Tris-
glycine SDS-polyacrylamide gels (Novex) or 4–12% Nu-
PAGE Bis-Tris gels (Novex). Gels were fixed by soaking in
50% methanol and 10% glacial acetic acid and then fluoro-
graphed in Amplify (Amersham). [35S]Methionine-labeled
proteins were detected on film (Biomax MR; Kodak).
Translation reactions were immunoprecipitated with S-
agarose or anti-His mouse monoclonal antibody (Penta-His;
Qiagen). Translation reactions were added to 250 l RIPA
buffer (15 M NaCl, 1% sodium deoxycholate, 1% Triton
X-100, 0.1% sodium dodecyl sulfate, 10 mM Tris-HCI, pH
7.2, and aprotinin, 2 g/ml), incubated on ice for 10 min,
and clarified by centrifugation at 20,000 g for 20 min at
4°C. Clarified supernatants were incubated with 50 l Pro-
tein G (10% suspension in RIPA buffer; Pharmacia) for 15
min on a rotator at 4°C. Following centrifugation at 20,000g
for 1 min, clarified supernatants were transferred to new
tubes and antibody or S-agarose (50 l) was added and then
incubated overnight at 4°C. Protein G-agarose was added to
samples containing antibody and incubated for 30 min at 4°C
on a rotator. Beads were pelleted by centrifugation at 20,000g
for 1 min and washed once in RIPA buffer, twice in each of the
following; buffer A (1 M NaCl, 10 mM Tris-HCI, pH 7.2,
0.1% NP-40), buffer B (0.1 M NaCl, 1 mM EDTA, 10 mM
Tris-HCI, pH 7.2, 0.1% NP-40, 0.3% SDS), and buffer C (10
mM Tris-HCI, pH 7.2, 0.1% NP-40). After the final wash,
beads were resuspended in 2X SDS buffer (35 l; Bio-Rad),
heated at 100°C for 5 min, and centrifuged at 20,000g for 5
min. Supernatants were analyzed by SDS-PAGE and fluorog-
raphy as described above.
Expression of NV proteinase and pro-pol fusion proteins
E. coli BL21-CodonPlus(DE3)-RIL (Stratagene) were
transformed with the expression plasmids pET41a/pro or
pET41a/pro-pol. Transformed cells were grown in LB me-
dium (Gibco/BRL) with shaking at 37°C in the presence of
kanamycin (30 g/ml). Expression was induced when the
culture reached OD600  0.8 by the addition of isopropyl-
-D-thiogalactopyranoside (IPTG) to a final concentration
of 1 mM. Cultures were harvested by centrifugation at
5000g for 10 min at 3 h postinduction for pET41a/pro or at
time points indicated in the figure legends for pET41a/pro-
pol. Levels of protein expression were monitored by anal-
ysis of cell lysates by SDS-PAGE or Western blotting with
polyclonal antisera against NV proteinase or polymerase.
Purification of NV proteinase
Cell pellets were resuspended in BugBuster reagent (Nova-
gen) corresponding to 1/25 of the original culture volume;
Benzonase nuclease (Novagen) was added (25 units/ml) and
incubated for 30 min at room temperature with gentle shaking.
NV proteinase was recovered in the soluble fraction following
removal of cell debris by centrifugation at 16,000g for 20 min
at 4°C. GST-proteinase was purified by affinity chromatogra-
phy as directed by the manufacturer (GST-bind purification kit;
Novagen). Purified GST-proteinase was incubated with biotin-
ylated thrombin (0.04 U/ul) to release NV proteinase. Throm-
bin and the GST-tag were removed with Streptavidin agarose
(Thrombin cleavage capture kit; Novagen) and GST-bind af-
finity resin (Novagen).
Proteinase assay
Proteolytic activity of purified NV proteinase was de-
tected using full-length ORF1 protein as substrate. [35S]Me-
thionine-labeled ORF1C1239G was prepared by in vitro
transcription-translation as described above. Aliquots of the
translation reaction (2.5 l) were diluted in protease buffer
(50 mM Tris-HCI, pH 7.6, 1 mM EDTA, 50 mM NaCl, 1
mM DTT); purified proteinase was added and reactions
were incubated at 30°C for 60 min, unless otherwise spec-
ified in the figure legends. Reactions were terminated by
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addition of an equal volume of 2X SDS dissociation buffer
and analyzed by SDS-PAGE and fluorography, as above.
The susceptibility of NV proteinase to inhibitors was
tested by adding inhibitors to the proteinase assay at the
following final concentrations: ZnCl2, 0.25, 2.5, and 25
mM; TLCK, 12.5, 125, and 375 g/ml; TPCK, 10, 100, and
500 g/ml; PMSF, 17.5, 175, and 750 g/ml; antipain, 5,
50, and 500 g/ml; bestatin, 4, 40, and 400 g/ml; E-64, 1,
10, and 100 g/ml; leupeptin, 0.5, 5, and 50 g/ml; aproti-
nin, 0.2, 2, and 20 g/ml; and pefabloc, 0.05, 0.5, and 5
mg/ml. Protease inhibitors were obtained from Roche Di-
agnostics. Samples were analyzed by SDS-PAGE and quan-
tified following imaging using Storm 820 Phosphoimager
(Molecular Dynamics) and ImageQuant 5.1 software. Per-
centage cleavage inhibition was determined in comparision
to substrate incubated in the absence of proteinase and
presence of proteinase without inhibitors.
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